Exhibit 99.2
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Revenue | $ | 125,317 | $ | 112,668 | $ | 238,079 | $ | 219,615 | ||||||||
Cost of operations | 51,596 | 54,243 | 98,539 | 107,714 | ||||||||||||
Sales and marketing | 31,422 | 31,822 | 62,355 | 61,925 | ||||||||||||
General and administrative | 24,282 | 21,746 | 47,816 | 50,768 | ||||||||||||
Depreciation and amortization | 6,635 | 6,713 | 13,488 | 13,643 | ||||||||||||
Interest income | 17 | 34 | 38 | 45 | ||||||||||||
Interest expense | 5,832 | 5,832 | 11,664 | 11,668 | ||||||||||||
Gain on investments | — | — | — | 8,074 | ||||||||||||
Other expense | 1,353 | 1,097 | 1,353 | 2,297 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Income (loss) from continuing operations before income tax provision (benefit) | 4,214 | (8,751 | ) | 2,902 | (20,281 | ) | ||||||||||
Income tax provision (benefit) | 1,603 | (2,649 | ) | 1,829 | (6,402 | ) | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Income (loss) from continuing operations | 2,611 | (6,102 | ) | 1,073 | (13,879 | ) | ||||||||||
Income from discontinued operations, net of tax | — | 508 | — | 508 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) | $ | 2,611 | $ | (5,594 | ) | $ | 1,073 | $ | (13,371 | ) | ||||||
|
|
|
|
|
|
|
| |||||||||
Basic income (loss) per common share: | ||||||||||||||||
Income (loss) from continuing operations | $ | 0.05 | $ | (0.12 | ) | $ | 0.02 | $ | (0.26 | ) | ||||||
Income from discontinued operations | — | 0.01 | — | 0.01 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) | $ | 0.05 | $ | (0.11 | ) | $ | 0.02 | $ | (0.25 | ) | ||||||
|
|
|
|
|
|
|
| |||||||||
Diluted income (loss) per common share: | ||||||||||||||||
Income (loss) from continuing operations | $ | 0.05 | $ | (0.12 | ) | $ | 0.02 | $ | (0.26 | ) | ||||||
Income from discontinued operations | — | 0.01 | — | 0.01 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) | $ | 0.05 | $ | (0.11 | ) | $ | 0.02 | $ | (0.25 | ) | ||||||
|
|
|
|
|
|
|
| |||||||||
Weighted-average shares outstanding used in computing income (loss) per common share: | ||||||||||||||||
Basic | 49,315 | 49,615 | 49,161 | 52,692 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Diluted | 50,925 | 49,615 | 50,175 | 52,692 | ||||||||||||
|
|
|
|
|
|
|
|
WEBMD HEALTH CORP.
CONSOLIDATED SUPPLEMENTAL FINANCIAL INFORMATION
(In thousands, unaudited)
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Revenue | ||||||||||||||||
Public portal advertising and sponsorship | $ | 105,783 | $ | 93,744 | $ | 199,221 | $ | 181,520 | ||||||||
Private portal services | 19,534 | 18,924 | 38,858 | 38,095 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
$ | 125,317 | $ | 112,668 | $ | 238,079 | $ | 219,615 | |||||||||
|
|
|
|
|
|
|
| |||||||||
Earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”) (a) | $ | 29,241 | $ | 14,238 | $ | 50,530 | $ | 25,489 | ||||||||
Interest, taxes, non-cash and other items (b) | ||||||||||||||||
Interest income | 17 | 34 | 38 | 45 | ||||||||||||
Interest expense | (5,832 | ) | (5,832 | ) | (11,664 | ) | (11,668 | ) | ||||||||
Income tax (provision) benefit | (1,603 | ) | 2,649 | (1,829 | ) | 6,402 | ||||||||||
Depreciation and amortization | (6,635 | ) | (6,713 | ) | (13,488 | ) | (13,643 | ) | ||||||||
Non-cash stock-based compensation | (11,224 | ) | (9,381 | ) | (21,161 | ) | (26,281 | ) | ||||||||
Gain on investments | — | — | — | 8,074 | ||||||||||||
Other expense | (1,353 | ) | (1,097 | ) | (1,353 | ) | (2,297 | ) | ||||||||
|
|
|
|
|
|
|
| |||||||||
Income (loss) from continuing operations | 2,611 | (6,102 | ) | 1,073 | (13,879 | ) | ||||||||||
Income from discontinued operations, net of tax | — | 508 | — | 508 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) | $ | 2,611 | $ | (5,594 | ) | $ | 1,073 | $ | (13,371 | ) | ||||||
|
|
|
|
|
|
|
|
(a) | See Annex A-Explanation of Non-GAAP Financial Measures. |
(b) | Reconciliation of Adjusted EBITDA to net income (loss). |
WEBMD HEALTH CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
June 30, 2013 | December 31, 2012 | |||||||
(unaudited) | ||||||||
Assets | ||||||||
Cash and cash equivalents | $ | 1,026,139 | $ | 991,835 | ||||
Accounts receivable, net | 103,793 | 106,622 | ||||||
Prepaid expenses and other current assets | 17,520 | 13,882 | ||||||
Deferred tax assets | 10,232 | 10,328 | ||||||
|
|
|
| |||||
Total current assets | 1,157,684 | 1,122,667 | ||||||
Property and equipment, net | 61,223 | 66,604 | ||||||
Goodwill | 202,104 | 202,104 | ||||||
Intangible assets, net | 14,970 | 16,105 | ||||||
Deferred tax assets | 52,711 | 56,039 | ||||||
Other assets | 24,182 | 27,106 | ||||||
|
|
|
| |||||
Total Assets | $ | 1,512,874 | $ | 1,490,625 | ||||
|
|
|
| |||||
Liabilities and Stockholders’ Equity | ||||||||
Accrued expenses | $ | 53,338 | $ | 64,256 | ||||
Deferred revenue | 98,325 | 92,176 | ||||||
Liabilities of discontinued operations | 1,506 | 1,506 | ||||||
|
|
|
| |||||
Total current liabilities | 153,169 | 157,938 | ||||||
2.25% convertible notes due 2016 | 400,000 | 400,000 | ||||||
2.50% convertible notes due 2018 | 400,000 | 400,000 | ||||||
Other long-term liabilities | 22,498 | 22,698 | ||||||
Stockholders’ equity | 537,207 | 509,989 | ||||||
|
|
|
| |||||
Total Liabilities and Stockholders’ Equity | $ | 1,512,874 | $ | 1,490,625 | ||||
|
|
|
|
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
Six Months Ended June 30, | ||||||||
2013 | 2012 | |||||||
Cash flows from operating activities: | ||||||||
Net income (loss) | $ | 1,073 | $ | (13,371 | ) | |||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
Income from discontinued operations, net of tax | — | (508 | ) | |||||
Depreciation and amortization | 13,488 | 13,643 | ||||||
Non-cash interest, net | 2,163 | 2,163 | ||||||
Non-cash stock-based compensation | 21,161 | 26,281 | ||||||
Deferred income taxes | 856 | (6,870 | ) | |||||
Gain on investments | — | (8,074 | ) | |||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | 2,829 | 24,501 | ||||||
Prepaid expenses and other, net | (3,060 | ) | (4,469 | ) | ||||
Accrued expenses and other long-term liabilities | (10,665 | ) | (9,128 | ) | ||||
Deferred revenue | 6,149 | 1,230 | ||||||
|
|
|
| |||||
Net cash provided by operating activities | 33,994 | 25,398 | ||||||
Cash flows from investing activities: | ||||||||
Proceeds received from ARS option | — | 9,269 | ||||||
Purchases of property and equipment | (7,367 | ) | (16,606 | ) | ||||
|
|
|
| |||||
Net cash used in investing activities | (7,367 | ) | (7,337 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from exercise of stock options | 10,340 | 816 | ||||||
Cash used for withholding taxes due on stock-based awards | (1,745 | ) | (1,958 | ) | ||||
Purchases of treasury stock | (1,281 | ) | (173,910 | ) | ||||
Excess tax benefit on stock-based awards | 363 | — | ||||||
|
|
|
| |||||
Net cash provided by (used in) financing activities | 7,677 | (175,052 | ) | |||||
|
|
|
| |||||
Net increase (decrease) in cash and cash equivalents | 34,304 | (156,991 | ) | |||||
Cash and cash equivalents at beginning of period | 991,835 | 1,121,217 | ||||||
|
|
|
| |||||
Cash and cash equivalents at end of period | $ | 1,026,139 | $ | 964,226 | ||||
|
|
|
|